Who
David R. Wells
Director
Company insider
Files Form 4 as: Director, HeartSciences; Chief Financial Officer, Envoy Medical; Chief Financial Officer, ENDRA Life Sciences; President, CFO, Sionix.
In numbers
- Trades disclosed
- 57
- Buys
- 11
- Sells
- 2
- Bought
- $54K
- Sold
- $32K
- Companies
- 4
- Companies where not an officer
- 1
- First trade
- 29 Mar 2010
- Last trade
- 12 Jan 2026
- Last filed
- 12 Jan 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 12 Jan 2026filed 12 Jan 2026 | HSCS HeartSciencesoption or derivative · Medical Devices | SEC FORM 4 Code A | —15,000 at $0.00 | filing |
| 12 Jan 2026filed 12 Jan 2026 | HSCS HeartSciencesoption or derivative · Medical Devices | SEC FORM 4 Code A | —15,000 at $0.00 | filing |
| 9 Jul 2025filed 11 Jul 2025 | HSCS HeartSciencesoption or derivative · Medical Devices | SEC FORM 4 Code A | —25,000 | filing |
| 16 Jan 2025filed 21 Jan 2025 | HSCS HeartSciencesoption or derivative · Medical Devices | SEC FORM 4 Code A | —6,000 | filing |
| 15 Oct 2023filed 17 Oct 2023 | COCH Envoy Medicaloption or derivative · Medical Devices | SEC FORM 4 Code A | —293,250 at $0.00 | filing |
| 20 Mar 2023filed 22 Mar 2023 | HSCS HeartSciencesoption or derivative · Medical Devices | SEC FORM 4 Code A | —50,000 | filing |
| 5 Apr 2021filed 7 Apr 2021 | NDRA ENDRA Life Sciencesoption or derivative · Medical Devices | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 6 Jan 2021filed 6 Jan 2021 | NDRA ENDRA Life SciencesMedical Devices | SEC FORM 4 Sold | $31K34,900 at $0.90 | filing |
| 5 Jan 2021filed 6 Jan 2021 | NDRA ENDRA Life SciencesMedical Devices | SEC FORM 4 Sold | $90100 at $0.90 | filing |
| 23 Jun 2020filed 24 Jun 2020 | NDRA ENDRA Life Sciencesoption or derivative · Medical Devices | SEC FORM 4 Code X | —5,000 at $0.00 | filing |
| 23 Jun 2020filed 24 Jun 2020 | NDRA ENDRA Life SciencesMedical Devices | SEC FORM 4 Code X | $4,3505,000 at $0.87 | filing |
| 8 Jun 2020filed 10 Jun 2020 | NDRA ENDRA Life Sciencesoption or derivative · Medical Devices | SEC FORM 4 Code C | $9,9968.74 at $1,143.68 | filing |
| 8 Jun 2020filed 10 Jun 2020 | NDRA ENDRA Life SciencesMedical Devices | SEC FORM 4 Code C | $9,00510,350 at $0.87 | filing |
| 9 Apr 2020filed 13 Apr 2020 | NDRA ENDRA Life SciencesMedical Devices | SEC FORM 4 Code A | —79,653 at $0.00 | filing |
| 25 Jan 2020filed 28 Jan 2020 | NDRA ENDRA Life Sciencesoption or derivative · Medical Devices | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 11 Dec 2019filed 11 Dec 2019 | NDRA ENDRA Life Sciencesoption or derivative · Medical Devices | SEC FORM 4 Code A | —138,375 at $0.00 | filing |
| 11 Dec 2019filed 11 Dec 2019 | NDRA ENDRA Life Sciencesoption or derivative · Medical Devices | SEC FORM 4 Code A | $9,9968.74 at $1,143.68 | filing |
| 11 Dec 2019filed 11 Dec 2019 | NDRA ENDRA Life Sciencesoption or derivative · Medical Devices | SEC FORM 4 Code A | —10,051 | filing |
| 27 Sep 2019filed 30 Sep 2019 | NDRA ENDRA Life SciencesMedical Devices | SEC FORM 4 Bought | $12K10,000 at $1.18 | filing |
| 23 Aug 2019filed 26 Aug 2019 | NDRA ENDRA Life SciencesMedical Devices | SEC FORM 4 Bought | $7,7505,000 at $1.55 | filing |
News
No headline names them, or the companies they trade most, lately.